ethyl 8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate

Catalog No. :
ACZIHP304
CAS No. :
94110-86-8
Molecular Formula :
C12H10N2O5
Molecular Weight :
262.22

IUPAC Name:ethyl 8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate

ethyl 8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$193.00Login to see priceIn stockInquiry
1g95%$559.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nameethyl 8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate
IUPAC Nameethyl 8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate
Molecular FormulaC12H10N2O5
Molecular Weight262.22
SMILESO=C(C1=C(O)C2=CC=CC([N+]([O-])=O)=C2N=C1)OCC
InChI KeyZTAWASGMGQOLHO-UHFFFAOYSA-N
Synonymethyl 8-nitro-4-oxo-3,4-dihydroquinoline-3-carboxylate;1,4-dihydro-8-nitro-4-oxo-3-quinolinecarboxylic acid ethyl ester;3-Quinolinecarboxylic acid, 1,4-dihydro-8-nitro-4-oxo-, ethyl ester;ethyl 8-nitro-4-oxo-3H-quinoline-3-carboxylate
CAS No.94110-86-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACZIHP304 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACZUCY621 route compound structure diagram
    ACZUCY62135973-25-2 In Stock
  4. Then
  5. ACZIHP304 route product structure diagram
    ACZIHP30494110-86-8 In Stock
Inquiry

2. ACZIHP304 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACZUCY621 route compound structure diagram
    ACZUCY62135973-25-2 In Stock
  4. Then
  5. ACZIHP304 route product structure diagram
    ACZIHP30494110-86-8 In Stock
Inquiry

Comments (0)